Lmr Partners LLP Horizon Therapeutics Public LTD CO Transaction History

Lmr Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $6.41 Million - $7.49 Million	64,731 Added 5.68%	1,203,870 $139 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $32.1 Million - $37.4 Million	332,933 Added 41.3%	1,139,139 $117 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $73.4 Million - $77.6 Million	683,491 Added 556.97%	806,206 $88 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $7.19 Million - $13.1 Million	115,215 Added 1536.2%	122,715 $14 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $595,500 - $872,700	7,500 New	7,500 $598,000

Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $7.88 Million - $9.93 Million	-117,673 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $6.5 Million - $9.41 Million	117,673 New	117,673 $9.14 Million
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $1.36 Million - $1.96 Million	-53,413 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $1.22 Million - $1.52 Million	53,413 New	53,413 $1.29 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.